All practice questions

4736 questions

All types4,736 Multiple choice2,413 Multiple select567 Numeric127 Matching858 Ordering771

An overweight 45-year-old female is evaluated in an urgent care clinic for severe, right-sided upper abdominal pain that started after eating a large, fatty meal last night. The pain occasionally radiates to her right shoulder. She also complains of nausea. Her current temperature is 38.1°C (100.6°F) and heart rate is 98/min. During the abdominal assessment, the clinician applies deep, firm palpation just below the right rib cage and instructs the patient to take a slow, deep breath. The patient abruptly catches her breath and stops inhaling midway due to a sudden spike in focal pain. Which of the following conditions is most strongly supported by this specific examination maneuver?

Acute pancreatitis

Acute cholecystitis

Choledocholithiasis

Acute cholangitis

Right lower lobe pneumonia

Show answer & explanation

Answer: Acute cholecystitis

Answer

Acute cholecystitis is the most likely diagnosis due to the presence of a classic Murphy's sign.

The correct answer is acute cholecystitis because the patient exhibits a classic positive Murphy's sign. During deep inspiration, the diaphragm descends, pushing the liver and an inflamed gallbladder down toward the examiner's palpating fingers. When the inflamed gallbladder makes contact, the patient experiences a sudden, sharp pain that causes an abrupt arrest in inspiration. This physical examination finding is highly indicative of acute cholecystitis and helps distinguish it from other hepatobiliary or pulmonary pathologies.

Step-by-Step Solution

Analyze the patient's demographic profile and history of present illness.

The patient is a 45-year-old female with postprandial right upper quadrant pain radiating to the shoulder, nausea, and low-grade fever.

This establishes a classic clinical picture of biliary tract disease, narrowing the differential diagnosis.

Evaluate the specific physical examination maneuver performed.

The clinician applied deep subcostal palpation during patient inhalation, which resulted in a sudden halt in inspiration due to pain.

Identifying the eponymous sign (Murphy's sign) is crucial for linking the physical finding to the underlying pathophysiology.

Correlate the physical examination finding with the correct medical condition.

The positive Murphy's sign occurs when the inflamed gallbladder descends and contacts the examiner's fingers, which is specific to acute cholecystitis.

This definitively differentiates acute cholecystitis from other causes of right upper quadrant pain.

Key Concept

Murphy's sign is a highly sensitive and specific physical examination finding for acute cholecystitis.

Question 542Question →

A 14-month-old girl is brought to the pediatric clinic by her parents due to delayed walking and bowing of her legs. On physical examination, the child's length and weight are at the 10th percentile for her age. She has mild frontal bossing, a flat nasal bridge, and distinctly blue sclerae. Radiographs of the lower extremities reveal anterior bowing of the tibiae and a healing fracture of the right fibula, which the parents did not realize had occurred. A skin biopsy is performed, and molecular analysis of cultured fibroblasts demonstrates a single missense mutation in the *COL1A1* gene, resulting in a bulky amino acid substituting for a critical glycine residue. The geneticist notes that this specific single-nucleotide substitution causes a much more severe clinical phenotype than if the patient had inherited a complete deletion of one *COL1A1* allele. Which of the following best describes the molecular mechanism responsible for this discrepancy in disease severity?

The mutant polypeptide chain incorporates into the multimeric protein complex and disrupts its overall structural integrity

A single normally functioning allele is incapable of producing an adequate quantity of protein to maintain tissue integrity

The phenotypic severity is dictated by the synergistic effect of inherited genetic mutations located on different chromosomes

Expansion of non-coding nucleotide repeats within the gene leads to progressive transcriptomic dysfunction

Epigenetic silencing of the unaffected allele via hypermethylation prevents compensatory transcription of the normal gene product

Show answer & explanation

Answer: The mutant polypeptide chain incorporates into the multimeric protein complex and disrupts its overall structural integrity

Answer

The mechanism is that the mutant polypeptide chain incorporates into the multimeric protein complex and disrupts its overall structural integrity (a dominant negative effect).

The patient's presentation of blue sclerae, skeletal deformities, and unexplained fractures is characteristic of osteogenesis imperfecta (OI). OI is primarily caused by defects in type I collagen, a multimeric protein forming a triple helix composed of two alpha-1 chains (encoded by the COL1A1 gene) and one alpha-2 chain (encoded by the COL1A2 gene). The correct answer describes a dominant negative effect, which occurs when an abnormal mutant protein interferes with the function of the wild-type protein translated from the normal allele. In OI, a missense mutation that substitutes a bulky amino acid for a glycine residue prevents the tight coiling required for the triple helix. Because the mutant alpha chains are incorporated alongside normal chains into the trimer, the vast majority of resulting collagen molecules are structurally defective and quickly degraded, leading to a severe clinical phenotype (e.g., OI types II, III, or IV). Conversely, a complete deletion of one allele (a null mutation) results in haploinsufficiency; the body produces only half the normal amount of collagen, but all the collagen produced is structurally normal, resulting in a significantly milder phenotype (OI type I).

Step-by-Step Solution

Diagnose the patient based on clinical findings.

The patient has osteogenesis imperfecta (OI), characterized by blue sclerae, skeletal deformities, and recurrent fractures.

Recognizing the disease is necessary to identify the involved protein, which is type I collagen.

Identify the structural characteristics of the affected protein.

Type I collagen is a multimeric protein consisting of a triple helix formed by two alpha-1 chains (COL1A1) and one alpha-2 chain (COL1A2).

The quaternary structure of the protein dictates how different types of genetic mutations manifest clinically.

Compare the consequences of a complete allele deletion versus a missense mutation.

A deletion leaves only one functional allele, producing half the normal amount of structurally sound collagen. A missense mutation produces defective chains that bind to normal chains, ruining the entire triple helix.

This comparison directly answers why the missense mutation produces a more severe phenotype.

Select the genetic principle matching the structural disruption.

The disruption of a multimeric complex by a mutant subunit is known as a dominant negative effect.

This terminology perfectly correlates with the molecular mechanism required by the prompt.

Key Concept

In multimeric proteins like type I collagen, a missense mutation that produces a structurally defective subunit often causes a more severe phenotype (via a dominant negative effect) than a null mutation that produces no subunit (which results in milder haploinsufficiency).

Estimated Time:1m 30s

Question 543Question →

During a musculoskeletal evaluation, various provocative physical maneuvers are utilized to isolate specific anatomical structures. Match each physical examination maneuver to the specific musculoskeletal pathology it is primarily used to identify.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches are: Finkelstein test with De Quervain tenosynovitis; McMurray test with Meniscal tear; Lachman test with Anterior cruciate ligament tear; and Empty can (Jobe) test with Supraspinatus tendon tear.

Each physical examination maneuver accurately aligns with the specific musculoskeletal pathology it was designed to isolate based on anatomic and biomechanical principles.

Step-by-Step Solution

Analyze the Finkelstein test mechanism.

Recognize that it stretches the first dorsal compartment of the wrist.

Pain with this stretch points to De Quervain tenosynovitis.

Analyze the McMurray test mechanism.

Recognize that it compresses and rotates the knee joint line.

A click or catch during this motion is classic for a meniscal tear.

Analyze the Lachman test mechanism.

Recognize that it tests the anterior-posterior stability of the knee at 30 degrees of flexion.

This is the most sensitive physical exam finding for an anterior cruciate ligament (ACL) tear.

Analyze the Empty can test mechanism.

Recognize that internal rotation and abduction in the scapular plane isolates specific rotator cuff muscles.

This positioning specifically tests the integrity of the supraspinatus tendon.

Key Concept

Musculoskeletal Provocative Testing

Estimated Time:1m 0s

Question 544Question →

A clinical pharmacologist is assisting the critical care team with dosing adjustments for patients experiencing severe hemodynamic and metabolic derangements. The relationship between hepatic blood flow ( $Q$ ), intrinsic hepatocellular clearance ( $Cl_{int}$ ), and the fraction of unbound drug ( $f_u$ ) mathematically dictates the disposition of hepatically cleared medications. Carefully evaluate the following patient scenarios and drug properties. Pair each specific clinical scenario with its most accurate primary pharmacokinetic consequence.

Click a left item, then click its matching right item

Show answer & explanation

Answer

1 matches with hepatic blood perfusion rate-limitation, 2 matches with intrinsic metabolic capacity enhancement, 3 matches with increased total clearance but unchanged free concentration, and 4 matches with increased systemic bioavailability due to evaded first-pass metabolism.

The matching correctly links physiological derivations of the general hepatic clearance equation to specific clinical perturbations, recognizing that high-extraction drugs are flow-limited (

Cl_H \approx Q

) while low-extraction drugs are capacity- and binding-limited (

Cl_H \approx f_u \times Cl_{int}

Step-by-Step Solution

Analyze the pharmacokinetic formula for hepatic clearance

Cl_H = Q \times (f_u \times Cl_{int}) / (Q + f_u \times Cl_{int})

This formula fundamentally differentiates how high-extraction and low-extraction drugs respond to physiological changes.

Evaluate high-extraction ratio drugs given intravenously

Since

f_u \times Cl_{int} \gg Q

, the denominator approximates to

f_u \times Cl_{int}

, simplifying the equation to

Cl_H \approx Q

. Therefore, cardiogenic shock (decreased

Q

) directly reduces clearance.

Identifies the correct match for the propofol/cardiogenic shock scenario.

Evaluate low-extraction ratio drugs given intravenously

Since

Q \gg f_u \times Cl_{int}

, the denominator approximates to

Q

, simplifying the equation to

Cl_H \approx f_u \times Cl_{int}

. Therefore, enzyme inducers (increased

Cl_{int}

) directly increase clearance.

Identifies the correct match for the ropivacaine/CYP induction scenario.

Analyze the effect of protein binding changes on low-extraction ratio drugs

Hypoalbuminemia increases

f_u

, which increases total

Cl_H

. The total steady-state concentration drops (

Css = Dose / Cl_{total}

). However, the free steady-state concentration (

Css_{free} = f_u \times Css = f_u \times (Dose / (f_u \times Cl_{int})) = Dose / Cl_{int}

) remains unchanged.

Explains the non-intuitive behavior of highly protein-bound, low-extraction drugs like phenytoin during hypoalbuminemia.

Evaluate high-extraction ratio drugs given orally during portosystemic shunting

Shunting causes orally absorbed drug to bypass the liver entirely before entering systemic circulation, massively increasing the area under the curve (AUC) and bioavailability.

Identifies the correct match for the propranolol/cirrhosis scenario.

Key Concept

Hepatic Clearance Kinetics, Extraction Ratios, and Protein Binding

Question 545Question →

A $32$ -year-old industrial worker is brought to the emergency department after losing consciousness in a metal plating facility. Coworkers report a chemical spill occurred shortly before he collapsed. On examination, he is comatose with a respiratory rate of $28$ /min and a heart rate of $120$ /min. His skin appears flushed. A faint "bitter almond" odor is noted on his clothing. Arterial blood gas analysis on room air reveals:

Parameter	Patient Value	Reference Range
pH	$7.12$	$7.35 - 7.45$
pCO $_2$	$24$ mmHg	$35 - 45$ mmHg
pO $_2$	$98$ mmHg	$80 - 100$ mmHg
HCO $_3^-$	$8$ mEq/L	$22 - 28$ mEq/L
Lactate	$14.5$ mmol/L	$0.5 - 1.0$ mmol/L

Which of the following describes the primary subcellular mechanism responsible for this patient's profound cellular injury?

Competitive binding to hemoglobin with an affinity significantly greater than oxygen, severely reducing oxygen-carrying capacity.

Increased permeability of the inner mitochondrial membrane to protons, uncoupling oxidative phosphorylation.

Systemic activation of the coagulation cascade resulting in microvascular thrombosis and impaired tissue perfusion.

Inhibition of mitochondrial cytochrome c oxidase by binding to its ferric iron component, preventing oxygen reduction.

Direct inhibition of the plasma membrane Na

^+

^+

ATPase, leading to cellular swelling and oncotic necrosis.

Show answer & explanation

Answer: Inhibition of mitochondrial cytochrome c oxidase by binding to its ferric iron component, preventing oxygen reduction.

Answer

Inhibition of mitochondrial cytochrome c oxidase by binding to its ferric iron component, preventing oxygen reduction.

The clinical presentation of rapid-onset coma, severe lactic acidosis, normal arterial oxygen tension, and a 'bitter almond' odor in a metal plating worker is pathognomonic for acute cyanide poisoning. Cyanide induces cellular injury by acting as a chemical asphyxiant. It rapidly crosses cell membranes and binds with high affinity to the ferric iron (Fe3+) within cytochrome c oxidase (Complex IV) of the mitochondrial electron transport chain. This binding completely blocks the transfer of electrons to oxygen, halting oxidative phosphorylation and ATP production. Consequently, cells are forced into anaerobic metabolism, generating massive amounts of lactate. Because tissues cannot extract oxygen from the blood, venous blood remains highly oxygenated, which clinically manifests as flushed skin.

Step-by-Step Solution

Analyze the clinical presentation and occupational history.

The patient is a metal plating worker presenting with sudden collapse, flushed skin, and a bitter almond odor, which strongly suggests acute chemical intoxication.

Metal plating is a high-risk occupation for cyanide exposure, and the bitter almond odor is a classic (though inconsistently detected) finding.

Interpret the laboratory findings.

The ABG shows severe high anion gap metabolic acidosis with a normal pO2 and markedly elevated lactate.

This profile indicates profound tissue hypoxia and reliance on anaerobic metabolism despite adequate oxygen delivery to the blood, pointing to chemical asphyxiation.

Identify the underlying toxicologic cellular mechanism.

Cyanide binds to the ferric iron (Fe3+) in cytochrome c oxidase (Complex IV) of the mitochondrial electron transport chain.

This interaction halts oxidative phosphorylation, preventing oxygen utilization and leading to rapid ATP depletion, cellular asphyxiation, and lactic acidosis.

Key Concept

Cyanide induces severe cellular injury by binding to the ferric iron (Fe3+) in cytochrome c oxidase (Complex IV), completely halting aerobic metabolism and ATP production.

Estimated Time:2m 0s

Question 546Question →

A $62$ -year-old woman is evaluated in the oncology clinic for progressive shortness of breath and right upper quadrant abdominal fullness over the past three weeks. She has a history of metastatic non-small cell lung cancer (NSCLC) diagnosed $20$ months ago. At the time of initial diagnosis, molecular testing of the lung primary tumor revealed an epidermal growth factor receptor (EGFR) exon $19$ deletion. She was started on osimertinib, with a robust partial response. She has no other significant past medical history and has never smoked. Current vital signs are within normal limits.

Physical examination reveals decreased breath sounds at the right lung base and a palpable, slightly tender liver edge $4$ cm below the right costal margin. Restaging computed tomography (CT) of the chest, abdomen, and pelvis demonstrates enlargement of the primary right lung mass, new right-sided pleural effusion, and multiple new, hypervascular hepatic lesions.

A liquid biopsy (cell-free DNA) is performed and confirms the presence of the original EGFR exon $19$ deletion but is negative for secondary EGFR mutations, including T790M and C797S, as well as MET amplification. Subsequently, an ultrasound-guided core needle biopsy of one of the new hepatic lesions is performed. Histopathologic evaluation of the liver specimen reveals sheets of small cells with scant cytoplasm, finely granular nuclear chromatin, and absent glandular architecture. Immunohistochemical staining is strongly positive for synaptophysin and chromogranin A.

Based on the patient's new clinicopathologic findings, which of the following is the most appropriate next step in management?

Initiate combination therapy with etoposide and a platinum agent

Discontinue current therapy and initiate an alternative epidermal growth factor receptor inhibitor

Continue current therapy and obtain an image-guided core biopsy of the enlarging primary lung mass

Order next-generation sequencing on the original archived lung tumor tissue

Add a programmed death-ligand 1 inhibitor to the patient's current targeted therapy regimen

Show answer & explanation

Answer: Initiate combination therapy with etoposide and a platinum agent

Answer

Initiate combination therapy with etoposide and a platinum agent

The correct answer is to initiate combination therapy with etoposide and a platinum agent. This patient with EGFR-mutated lung adenocarcinoma has developed acquired resistance to the third-generation EGFR inhibitor, osimertinib. While acquired secondary kinase domain mutations (such as C797S) and bypass track signaling (such as MET amplification) are common resistance mechanisms, approximately

3\%

15\%

of EGFR-mutated NSCLCs undergo lineage plasticity and transform into small cell lung cancer (SCLC). The recent liver biopsy exhibits classic SCLC histology: solid sheets of cells with scant cytoplasm, finely granular chromatin, absent glandular architecture, and positive staining for neuroendocrine markers (synaptophysin, chromogranin A). The original EGFR mutation is typically retained, as seen in this patient's cell-free DNA. Once histologic transformation to SCLC is confirmed, the tumor behaves clinically like primary SCLC. Therefore, standard-of-care management must pivot to an SCLC-directed cytotoxic chemotherapy regimen, typically a platinum agent combined with etoposide.

Step-by-Step Solution

Analyze the patient's initial diagnosis and current therapy.

The patient has EGFR-mutated NSCLC and has been receiving osimertinib for

20

months.

Establishing the baseline molecular profile is essential to understanding potential acquired resistance mechanisms.

Interpret the new biopsy findings from the progressing hepatic lesion.

The biopsy shows sheets of small cells, granular chromatin, and positivity for synaptophysin and chromogranin A, confirming neuroendocrine differentiation.

Identifying the precise histologic changes explains the clinical progression despite ongoing targeted therapy.

Synthesize the clinical history and pathology to determine the resistance mechanism.

The findings indicate histologic transformation from adenocarcinoma to small cell lung cancer (SCLC).

Accurate characterization of the tumor's new biology dictates the subsequent treatment strategy.

Determine the standard of care management for the newly identified tumor histology.

The appropriate treatment for extensive-stage SCLC is cytotoxic chemotherapy with a platinum agent and etoposide.

The tumor is no longer solely dependent on the EGFR pathway; therefore, EGFR inhibitors are insufficient, and SCLC requires aggressive chemotherapy.

Key Concept

Histologic transformation to small cell lung cancer (SCLC) is a known mechanism of acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC, presenting with neuroendocrine morphology and requiring a shift to SCLC-directed chemotherapy.

Question 547Question →

A 42-year-old woman is brought to the emergency department by her husband due to progressive confusion, unsteadiness, and hand tremors over the past 3 days. She has a history of bipolar disorder and has been stable on a fixed dose of lithium carbonate for the last three years. Two weeks ago, she was diagnosed with osteoarthritis of the knee and began taking a newly prescribed daily oral medication for joint pain. Her vital signs are temperature $37.0^\circ\text{C}$ ( $98.6^\circ\text{F}$ ), blood pressure $138/85\text{ mmHg}$ , pulse $88/\text{min}$ , and respiratory rate $14/\text{min}$ . Physical examination reveals a coarse resting tremor and marked ataxia. Laboratory studies show a serum lithium concentration of $2.1\text{ mEq/L}$ (therapeutic range: $0.6-1.2\text{ mEq/L}$ ) and a serum creatinine of $1.4\text{ mg/dL}$ (baseline: $0.8\text{ mg/dL}$ ). The newly prescribed medication is identified as the likely cause of her current condition. Which of the following pharmacokinetic mechanisms best explains this patient's acute toxicity?

Reduced glomerular filtration and enhanced proximal tubular reabsorption

Competitive inhibition of hepatic cytochrome P450 isoenzymes

Displacement of the psychiatric medication from plasma proteins

Decreased apparent volume of distribution due to acute fluid shifts

Enhanced gastrointestinal mucosal permeability and absorption

Show answer & explanation

Answer: Reduced glomerular filtration and enhanced proximal tubular reabsorption

Answer

Reduced glomerular filtration and enhanced proximal tubular reabsorption

The correct answer accurately links the physiologic effect of NSAIDs to the pharmacokinetic handling of lithium. The patient's elevated creatinine and lithium levels point to a renal interaction. NSAIDs inhibit the synthesis of vasodilatory prostaglandins, leading to vasoconstriction of the afferent arteriole. This reduces the glomerular filtration rate (GFR). In response to a lower GFR, the kidneys attempt to preserve volume by upregulating the reabsorption of sodium in the proximal tubule. Because the proximal tubule cannot distinguish well between sodium and lithium, lithium is reabsorbed alongside sodium, resulting in decreased lithium clearance and acute systemic toxicity.

Step-by-Step Solution

Identify the clinical syndrome and the likely offending agent.

The patient has acute lithium toxicity (tremor, ataxia, confusion, level of 2.1 mEq/L) triggered by a new medication for osteoarthritis, which is almost certainly a nonsteroidal anti-inflammatory drug (NSAID).

Connecting the new symptom onset with the osteoarthritis treatment establishes the drug-drug interaction context.

Determine the pharmacological effect of NSAIDs on renal physiology.

NSAIDs inhibit cyclooxygenase, decreasing prostaglandin production. Since prostaglandins normally dilate the afferent arteriole, their absence leads to afferent vasoconstriction and a decreased glomerular filtration rate (GFR).

Understanding the foundational mechanism of NSAID-induced nephrotoxicity is required to trace the pharmacokinetic impact.

Apply the altered renal physiology to the pharmacokinetics of lithium.

A decreased GFR triggers the kidneys to compensate by increasing sodium reabsorption in the proximal tubule. Because lithium is handled identically to sodium in this nephron segment, its reabsorption also increases, drastically reducing its clearance and causing toxic accumulation.

This confirms that reduced clearance via enhanced proximal reabsorption is the precise pharmacokinetic mechanism of the interaction.

Key Concept

NSAIDs cause lithium toxicity by inhibiting renal prostaglandin synthesis, which decreases afferent arteriolar blood flow and GFR, leading to a compensatory increase in the proximal tubular reabsorption of both sodium and lithium.

Estimated Time:1m 30s

Question 548Question →

A 45-year-old man with type 1 diabetes mellitus is brought to the emergency department after being found unresponsive by his wife. His capillary blood glucose is 32 mg/dL. He is administered intramuscular glucagon, which promptly restores his consciousness and raises his blood glucose levels by promoting hepatic glycogenolysis. Arrange the following steps of the intracellular signal transduction cascade in the correct chronological order, starting immediately after the medication reaches the hepatocyte.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Receptor binding -> Gs subunit activation -> cAMP generation -> PKA activation -> Target enzyme phosphorylation.

The sequence correctly traces the Gs-protein coupled receptor (GPCR) pathway utilized by glucagon. The process begins with the ligand binding the receptor on the cell surface. This induces a conformational change that activates the Gs protein, causing its alpha subunit to stimulate adenylyl cyclase. Adenylyl cyclase then converts ATP into cAMP. Increased levels of intracellular cAMP subsequently activate protein kinase A (PKA). Finally, PKA phosphorylates specific target enzymes, such as activating glycogen phosphorylase kinase and inactivating glycogen synthase, thereby promoting the rapid breakdown of glycogen and the release of glucose into the blood.

Step-by-Step Solution

Identify the receptor type for glucagon.

Glucagon acts on a Gs protein-coupled receptor (GPCR).

Understanding the receptor class is required to deduce the intracellular signaling pathway.

Trace the activation sequence of a Gs protein.

Ligand binding causes the Gs-alpha subunit to dissociate and activate adenylyl cyclase.

This is the direct membrane-bound consequence of GPCR activation.

Identify the secondary messenger produced by the effector enzyme.

Adenylyl cyclase converts ATP into cAMP.

cAMP acts as the intracellular amplifier for the hormone signal.

Determine the direct target of the secondary messenger.

cAMP binds to and activates Protein Kinase A (PKA).

PKA is the primary effector for cAMP-mediated cellular responses in this pathway.

Identify the final functional outcome of the cascade.

PKA phosphorylates downstream metabolic enzymes.

Phosphorylation activates glycogen phosphorylase kinase, directly leading to glycogenolysis.

Key Concept

Glucagon acts via a Gs protein-coupled receptor to increase cAMP, activate PKA, and phosphorylate metabolic enzymes to rapidly induce glycogenolysis.

Estimated Time:45s

Question 549Question →

A 68-year-old man is hospitalized for management of infective endocarditis involving a prosthetic aortic valve. Blood cultures drawn on admission grow methicillin-resistant *Staphylococcus aureus* (MRSA). He is started on intravenous vancomycin, and subsequent trough levels are maintained consistently between $15$ and $20 \mu\text{g/mL}$ . The patient's clinical status improves, and repeat blood cultures on day $4$ are sterile. However, on day $18$ of hospitalization, he develops a new fever of $38.9^\circ\text{C}$ ( $102.0^\circ\text{F}$ ) and worsening fatigue. Repeat blood cultures again grow MRSA. Susceptibility testing of the new bacterial isolate reveals a vancomycin minimum inhibitory concentration (MIC) of $4 \mu\text{g/mL}$ , compared to an initial MIC of $1 \mu\text{g/mL}$ . Which of the following best describes the molecular mechanism responsible for this pathogen's reduced susceptibility to the current therapy?

Synthesis of an abnormally thick peptidoglycan wall containing excessive target binding sites

Plasmid-mediated substitution of the terminal peptide precursor to D-alanyl-D-lactate

Chromosomal expression of a novel transpeptidase with reduced affinity for the drug

Acquisition of a gene cluster encoding a transmembrane antibiotic efflux pump

Production of an extracellular modifying enzyme that cleaves the drug's cyclic peptide structure

Show answer & explanation

Answer: Synthesis of an abnormally thick peptidoglycan wall containing excessive target binding sites

Answer

Synthesis of an abnormally thick peptidoglycan wall containing excessive target binding sites

The correct answer identifies the mechanism for Vancomycin-Intermediate Staphylococcus aureus (VISA). VISA typically emerges in patients receiving prolonged vancomycin therapy (such as for endocarditis or osteomyelitis) and is characterized by a gradual increase in the minimum inhibitory concentration (MIC), known as 'MIC creep.' An MIC of

4

8 \mu\text{g/mL}

defines VISA. The underlying pathophysiology involves spontaneous point mutations that alter cell wall metabolism, leading to the synthesis of an exceptionally thick peptidoglycan layer. This hyper-thickened wall contains a vast excess of D-alanyl-D-alanine terminal residues. These residues act as 'decoys' or a sponge, binding vancomycin molecules in the outer layers of the cell wall. Consequently, the drug becomes physically trapped and cannot penetrate deeply enough to reach the critically located cell membrane precursors where it normally exerts its inhibitory effect on cross-linking.

Step-by-Step Solution

Analyze the clinical scenario and the change in microbiological data.

A patient with MRSA endocarditis initially responding to vancomycin develops recurrent bacteremia. The MRSA isolate's vancomycin MIC has increased from

1 \mu\text{g/mL}

4 \mu\text{g/mL}

Identifying the shift in the MIC is crucial for diagnosing the specific type of antimicrobial resistance that has emerged during therapy.

Interpret the new vancomycin MIC value.

An MIC of

4 \mu\text{g/mL}

for Staphylococcus aureus indicates Vancomycin-Intermediate S. aureus (VISA). (Susceptible is <=

2 \mu\text{g/mL}

, Intermediate is

4-8 \mu\text{g/mL}

, Resistant is >=

16 \mu\text{g/mL}

Differentiating between intermediate and high-level resistance dictates the specific molecular mechanism involved.

Determine the molecular mechanism underlying VISA.

VISA emerges through stepwise chromosomal mutations that result in a markedly thickened peptidoglycan cell wall.

This thick wall contains abundant D-alanyl-D-alanine residues that act as false targets, trapping vancomycin in the outer cell wall and preventing it from reaching the critically located targets at the cytoplasmic membrane.

Key Concept

Vancomycin-Intermediate Staphylococcus aureus (VISA) resistance mechanism

Estimated Time:1m 30s

Question 550Question →

Match each clinical presentation described below with its primary underlying genetic or molecular pathophysiologic mechanism.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The presentations map to their respective molecular defects: Xeroderma pigmentosum corresponds to defective nucleotide excision repair; Huntington disease to toxic gain-of-function from trinucleotide expansion; Ataxia-telangiectasia to impaired nonhomologous end joining; and Marfan syndrome to mutant glycoprotein causing excessive TGF-beta signaling.

Each clinical vignette maps directly to a unique molecular pathway defect. Xeroderma pigmentosum results from a failure to repair UV-induced pyrimidine dimers via nucleotide excision repair. Huntington disease is caused by CAG trinucleotide repeat expansion, leading to a toxic gain-of-function huntingtin protein. Ataxia-telangiectasia is due to ATM gene mutations, disrupting the nonhomologous end joining repair of double-strand DNA breaks. Marfan syndrome is caused by FBN1 mutations, producing abnormal fibrillin-1 that fails to regulate TGF-beta signaling appropriately.

Step-by-Step Solution

Identify the clinical syndrome described in each vignette on the left.

The vignettes represent Xeroderma pigmentosum, Huntington disease, Ataxia-telangiectasia, and Marfan syndrome, respectively.

Accurate clinical diagnosis is the required first step before mapping the phenotype to a molecular defect.

Determine the specific genetic or molecular abnormality underlying each identified condition.

Xeroderma pigmentosum involves nucleotide excision repair; Huntington disease involves a polyglutamine tract causing protein misfolding; Ataxia-telangiectasia involves the ATM gene and nonhomologous end joining; Marfan syndrome involves fibrillin-1 and TGF-beta dysregulation.

Matching the clinical syndrome to its fundamental pathophysiology tests the core genetic mechanisms.

Key Concept

Understanding the precise molecular and genetic mechanisms underlying distinct clinical phenotypes is essential for accurate diagnosis and management of inherited disorders.

Question 551Question →

A 55-year-old man with a history of alcohol use disorder and compensated cirrhosis presents to the clinic to discuss an upcoming umbilical hernia repair. He reports no recent bleeding episodes, and a recent screening endoscopy showed small esophageal varices without stigmata of recent bleeding. Vital signs are within normal limits. Laboratory evaluation reveals:

* Hemoglobin: $12.4 \text{ g/dL}$
* Platelets: $85,000/\mu L$
* Prothrombin time (PT): $18 \text{ seconds}$ (Reference: $11-14 \text{ seconds}$ )
* INR: $1.7$
* Activated partial thromboplastin time (aPTT): $34 \text{ seconds}$ (Reference: $25-40 \text{ seconds}$ )

The surgeon expresses concern regarding the prolonged INR and requests a hematology consultation for preoperative optimization. The hematologist recommends proceeding with the surgery without the prophylactic administration of fresh frozen plasma. Which of the following principles of hemodynamics and coagulation best justifies this recommendation?

Commensurate decline in the production of endogenous anticoagulant proteins preserves the overall hemostatic balance.

Hepatic synthesis of antithrombin is upregulated to counteract the reduction in procoagulant factors and stabilize the clot.

The prolonged prothrombin time in this setting primarily reflects concurrent vitamin K deficiency rather than impaired factor synthesis.

Increased endothelial synthesis of factor VIII completely offsets the extrinsic pathway defect, preventing surgical hemorrhage.

A normal activated partial thromboplastin time confirms that adequate fibrinogen levels are present to support primary hemostasis.

Show answer & explanation

Answer: Commensurate decline in the production of endogenous anticoagulant proteins preserves the overall hemostatic balance.

Answer

Commensurate decline in the production of endogenous anticoagulant proteins preserves the overall hemostatic balance.

The correct answer identifies that patients with advanced liver disease develop a 'rebalanced hemostatic state.' The liver is responsible for synthesizing most procoagulant factors (e.g., Factors II, VII, IX, X), and their decline leads to a prolonged PT and INR. However, the liver also synthesizes critical endogenous anticoagulant proteins, specifically Protein C, Protein S, and Antithrombin. Because the production of these anticoagulants declines commensurately with the procoagulants, the overall hemostatic balance is often maintained. Therefore, a prolonged INR in a patient with cirrhosis does not reliably predict surgical bleeding risk, and the prophylactic administration of fresh frozen plasma is generally not recommended solely to correct the laboratory number.

Step-by-Step Solution

Analyze the patient's clinical presentation and laboratory findings.

The patient has established cirrhosis with expected thrombocytopenia and an elevated INR, but no clinical signs of abnormal bleeding.

To identify the baseline hemostatic status prior to an invasive surgical procedure.

Evaluate the specialist's recommendation to withhold prophylactic fresh frozen plasma (FFP).

The hematologist recognizes that an elevated INR in the setting of cirrhosis does not equate to a true bleeding diathesis.

Traditional coagulation tests (PT/INR) only measure procoagulant pathways and fail to capture the entire hemostatic picture in liver disease.

Identify the fundamental mechanism of hemostasis in patients with cirrhosis.

Cirrhosis causes a parallel, commensurate decrease in both liver-derived procoagulant factors (II, VII, IX, X, V, XI) and endogenous anticoagulant proteins (Protein C, Protein S, Antithrombin).

This physiological adaptation creates a 'rebalanced' hemostatic state, explaining why patients with cirrhosis can maintain adequate hemostasis during surgery despite abnormal traditional laboratory values.

Key Concept

Patients with cirrhosis exist in a 'rebalanced hemostatic state' due to a simultaneous decline in the hepatic synthesis of both procoagulant factors and endogenous anticoagulant proteins.

Estimated Time:2m 0s

Question 552Question →

A 38-year-old woman is admitted to the intensive care unit with profound hypotension, widespread purpuric skin lesions, and persistent oozing from her intravenous catheter sites following an emergency dilation and curettage for a septic abortion. Laboratory studies reveal a platelet count of $22,000/\text{mm}^3$ , a significantly prolonged prothrombin time, a decreased fibrinogen level, and a markedly elevated D-dimer. Arrange the pathophysiologic events underlying this patient's hematologic and hemodynamic collapse in the correct chronological sequence, from the initial trigger to the final clinical manifestation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct pathophysiologic sequence begins with the inflammatory upregulation of tissue factor, which triggers the extrinsic pathway leading to systemic thrombin generation. This causes widespread microvascular fibrin deposition, subsequently leading to the consumptive depletion of platelets and coagulation factors, and finally concluding with the secondary plasmin-mediated fibrinolysis that produces D-dimers and worsens the severe bleeding.

Disseminated intravascular coagulation (DIC) is characterized by an initial systemic procoagulant phase followed by a consumptive hemorrhagic phase. The sequence strictly begins with an inciting trigger (endothelial injury and tissue factor release), leading to uninhibited thrombin generation. Thrombin drives the formation of fibrin microthrombi (causing ischemia). The extensive creation of these clots consumes the available pool of platelets and coagulation factors. Finally, the body's endogenous fibrinolytic system (plasmin) breaks down these clots, elevating D-dimer levels and contributing to the bleeding diathesis via the inhibitory effects of fibrin degradation products.

Step-by-Step Solution

Identify the inciting event triggering the coagulation cascade.

Systemic inflammation (sepsis) causes endothelial damage and upregulates tissue factor.

Sepsis induces a cytokine storm that alters the normally antithrombotic endothelial surface to a prothrombotic state by exposing tissue factor to the bloodstream.

Determine the immediate biochemical consequence of tissue factor exposure.

Activation of the extrinsic pathway and massive thrombin generation.

Tissue factor is the primary physiologic initiator of coagulation; its widespread exposure leads to uncontrolled thrombin production.

Trace the direct effect of unregulated thrombin in the circulation.

Conversion of fibrinogen to fibrin, resulting in microvascular thrombosis.

Thrombin acts on fibrinogen to form fibrin meshes, which lodge in small vessels, leading to ischemia and red blood cell shearing (schistocytes).

Identify the mechanism behind the onset of the bleeding diathesis.

Profound consumption of platelets and coagulation factors.

Because the coagulation cascade is continuously activated systemically, the body's stores of platelets and soluble clotting factors are rapidly depleted.

Determine the counter-regulatory response and its clinical effect.

Secondary fibrinolysis generates fibrin degradation products (FDPs) like D-dimer.

Plasmin attempts to clear the widespread clots but generates FDPs, which interfere with further fibrin polymerization and platelet function, worsening the hemorrhage.

Key Concept

Pathophysiology and temporal sequence of Disseminated Intravascular Coagulation (DIC)

Question 553Question →

A 42-year-old man is brought to the emergency department by his wife due to a 3-week history of recurrent fevers, profound fatigue, night sweats, and new-onset shortness of breath with exertion. One month ago, he was hospitalized for a complicated methicillin-susceptible Staphylococcus aureus (MSSA) skin infection that was treated with a short course of oral antibiotics against medical advice. He appears acutely ill and diaphoretic. His temperature is 39.2°C (102.6°F), blood pressure is 110/50 mmHg, heart rate is 112/min, and respiratory rate is 22/min. Pulse oximetry shows 94% on ambient air. The physician suspects a severe, acute systemic intravascular infection. Which of the following physical examination findings are highly indicative of the most likely diagnosis in this patient? (Select all that apply)

Select all that apply

Painless, erythematous macules on the palms and soles

Tender, raised, violaceous nodules on the pads of the fingers

A blowing, holosystolic murmur heard best at the cardiac apex that radiates to the axilla

A low-pitched, rumbling diastolic murmur at the cardiac apex preceded by an opening snap

A harsh, crescendo-decrescendo systolic murmur at the left lower sternal border that increases in intensity during the Valsalva maneuver

Painless, non-pruritic, pink macules with central clearing on the trunk and inner surfaces of the limbs

Show answer & explanation

Answer: Painless, erythematous macules on the palms and soles; Tender, raised, violaceous nodules on the pads of the fingers; A blowing, holosystolic murmur heard best at the cardiac apex that radiates to the axilla

Answer

The correct findings are painless erythematous macules on the palms and soles (Janeway lesions), tender violaceous nodules on the finger pads (Osler nodes), and a blowing holosystolic murmur at the cardiac apex (mitral regurgitation).

The patient's presentation of high fevers, toxicity, and a recent incompletely treated Staphylococcal skin infection is highly suspicious for acute infective endocarditis (IE). The classic physical examination findings for IE reflect either direct valvular destruction or systemic embolization/immune complex deposition. A new blowing, holosystolic murmur at the apex radiating to the axilla indicates acute mitral regurgitation, which can occur due to leaflet perforation or chordal rupture from a vegetation. Furthermore, septic microemboli can cause painless, erythematous macules on the palms and soles known as Janeway lesions. Deposition of circulating immune complexes can lead to the formation of Osler nodes, which are tender, violaceous nodules on the pads of the fingers and toes. Recognizing this specific constellation of findings is essential for promptly diagnosing and managing this life-threatening condition.

Step-by-Step Solution

Analyze the patient's history and vital signs.

The patient has high fevers, toxicity, and a recent history of inadequately treated MSSA bacteremia.

To establish the primary clinical syndrome, which strongly points towards an acute, severe infection such as infective endocarditis.

Identify the classic physical examination manifestations associated with the suspected diagnosis.

Infective endocarditis is classically associated with valvular destruction (causing new regurgitant murmurs) and peripheral stigmata (vascular and immunologic phenomena).

To correlate the pathophysiology of the disease with the specific physical signs being tested.

Evaluate each answer choice for its association with infective endocarditis.

Janeway lesions (painless palmar/plantar macules), Osler nodes (tender finger nodules), and mitral regurgitation (holosystolic apical murmur) are all strongly indicative of this condition.

To confirm the correct constellation of findings and rule out distractors belonging to other cardiac conditions like rheumatic fever or hypertrophic cardiomyopathy.

Key Concept

Physical Examination Findings of Infective Endocarditis

Question 554Question →

Match each patient's clinical presentation with the most appropriate initial imaging modality.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct pairings are: the pregnant patient with ultrasound, the hemodynamically unstable trauma patient with FAST, the stable patient with tearing chest pain with CT angiography of the chest, and the patient with suspected pulmonary embolism with CT pulmonary angiography.

Each pairing represents the direct, high-yield application of clinical guidelines: ultrasound avoids radiation in early pregnancy, FAST allows rapid bedside evaluation without delaying stabilization in trauma, CT angiography accurately maps the aorta in stable dissection, and CT pulmonary angiography is the definitive study for pulmonary embolism.

Step-by-Step Solution

Analyze each clinical vignette to determine the most likely suspected diagnosis.

Identified suspected conditions: acute appendicitis in pregnancy, intra-abdominal hemorrhage from trauma, aortic dissection, and pulmonary embolism.

Identifying the primary differential diagnosis dictates the targeted imaging required.

Evaluate patient stability and specific contraindications (e.g., pregnancy).

Recognized that the trauma patient is too unstable for the CT scanner and the pregnant patient must avoid radiation.

Hemodynamic instability and pregnancy are major branch points in diagnostic imaging algorithms.

Match the clinical parameters with the standard-of-care imaging modality.

Assigned FAST for the unstable trauma patient, ultrasound for the pregnant patient, CT chest angiography for the stable dissection, and CT pulmonary angiography for the pulmonary embolism.

Following evidence-based guidelines ensures safe and accurate diagnosis.

Key Concept

Selecting the initial diagnostic imaging modality based on suspected pathology, hemodynamic stability, and contraindications like pregnancy.

Question 555Question →

A $74$ -year-old man with a history of nonvalvular atrial fibrillation and hypertension is admitted to the hospital with hemoptysis and a cavitary lung lesion. He is diagnosed with chronic pulmonary histoplasmosis. The infectious disease consultant recommends initiating therapy with oral itraconazole.

The patient's outpatient medications include rivaroxaban $20 \text{ mg}$ once daily and amlodipine $5 \text{ mg}$ once daily.

His baseline laboratory studies on admission show:
- Hemoglobin: $13.8 \text{ g/dL}$
- Serum creatinine: $1.2 \text{ mg/dL}$ (Estimated creatinine clearance: $58 \text{ mL/min}$ )

Four days after starting itraconazole, the patient develops acute-onset hematemesis and melena. He becomes hypotensive and tachycardic. Repeat laboratory studies show:
- Hemoglobin: $7.4 \text{ g/dL}$
- Serum creatinine: $1.4 \text{ mg/dL}$

Which of the following best describes the primary mechanism responsible for this patient's acute gastrointestinal hemorrhage?

Inhibition of both cytochrome P450-mediated hepatic metabolism and P-glycoprotein-mediated active efflux

Worsening renal function resulting in a profound decrease in the glomerular filtration of the anticoagulant

Initiation of an antifungal agent that is absolutely contraindicated due to the patient's concurrent use of a calcium channel blocker

Displacement of the anticoagulant from plasma binding proteins, leading to a transient increase in the pharmacologically active free fraction

Pharmacodynamic synergism at the factor Xa active site caused by the active metabolites of the antifungal agent

Show answer & explanation

Answer: Inhibition of both cytochrome P450-mediated hepatic metabolism and P-glycoprotein-mediated active efflux

Answer

The hemorrhage is caused by the inhibition of both cytochrome P450-mediated hepatic metabolism and P-glycoprotein-mediated active efflux.

The correct answer identifies the severe pharmacokinetic drug-drug interaction between direct oral anticoagulants (DOACs) and azole antifungals. Rivaroxaban's disposition depends on both cytochrome P450 3A4 (CYP3A4) for hepatic metabolism and P-glycoprotein (P-gp) for intestinal and renal efflux. Itraconazole is a potent inhibitor of both pathways. When coadministered, itraconazole prevents the metabolism and efflux of rivaroxaban, leading to a profound increase in the area under the curve (AUC) and peak plasma concentrations. This toxic accumulation directly resulted in the patient's acute, life-threatening gastrointestinal hemorrhage.

Step-by-Step Solution

Identify the primary active medications involved in the clinical change.

The patient is taking rivaroxaban (a direct oral anticoagulant) and was recently started on itraconazole (an azole antifungal).

Recognizing newly added medications is critical for identifying potential drug-drug interactions that precipitate acute clinical deterioration.

Analyze the pharmacokinetic properties of the anticoagulant.

Rivaroxaban is metabolized hepatically by CYP3A4 and is also a substrate for the P-glycoprotein (P-gp) efflux transporter in the gut and kidneys.

Understanding the clearance pathways of direct oral anticoagulants is necessary to predict how other drugs might alter their systemic levels.

Determine the pharmacokinetic effect of the newly added medication.

Itraconazole is a potent inhibitor of both CYP3A4 and P-gp.

Azole antifungals, macrolide antibiotics, and protease inhibitors are classic dual inhibitors of these specific metabolic and transport pathways.

Synthesize the interaction to explain the patient's presentation.

The dual inhibition drastically reduces rivaroxaban clearance and increases its bioavailability, leading to supratherapeutic plasma levels and severe gastrointestinal hemorrhage.

Connecting the pharmacokinetic mechanism directly to the adverse clinical outcome confirms the diagnosis.

Key Concept

Direct oral anticoagulants like rivaroxaban and apixaban rely heavily on CYP3A4 and P-glycoprotein for clearance; concomitant administration of potent dual inhibitors (e.g., itraconazole, ritonavir) leads to dangerous drug accumulation and severe bleeding.

Estimated Time:1m 30s

Question 556Question →

Review the following clinical presentations and histopathological findings. Match each patient scenario to the precise underlying subcellular mechanism or biochemical hallmark responsible for the described cellular adaptation or injury.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The clinical vignettes correlate with ischemia-reperfusion injury (ROS generation), intrinsic apoptosis (cytochrome c release), metaplasia (stem cell reprogramming), and coagulative necrosis (protein denaturation), respectively.

Each clinical scenario precisely matches a distinct cellular injury or adaptation mechanism. Reperfusion injury is driven by free radical generation; chemotherapy-induced apoptosis is mediated by mitochondrial cytochrome c; metaplasia stems from transcriptional reprogramming of basal cells; and coagulative necrosis is characterized by the denaturation of intracellular proteins due to severe acidosis.

Step-by-Step Solution

Analyze the first vignette describing early biomarker peaking and arrhythmias post-stenting.

Identify this as ischemia-reperfusion injury.

Re-establishing blood flow paradoxically exacerbates cellular damage via reactive oxygen species and mitochondrial permeability transition pore opening.

Analyze the second vignette describing single-cell death with chromatin condensation and no inflammation after chemotherapy.

Identify this as intrinsic apoptosis.

Chemotherapy induces DNA damage, which triggers mitochondrial cytochrome c release and caspase activation.

Analyze the third vignette describing squamous epithelium replacing columnar epithelium in a patient with night blindness.

Identify this as squamous metaplasia secondary to Vitamin A deficiency.

Vitamin A is required for maintaining specialized epithelia; its absence causes stem cell reprogramming toward a keratinized squamous phenotype.

Analyze the fourth vignette describing a wedge-shaped splenic infarct with preserved cellular outlines.

Identify this as coagulative necrosis.

Ischemic cell death in most solid organs results in intracellular acidosis that denatures proteins and enzymes, temporarily preserving the structural architecture.

Key Concept

Cellular adaptation and injury mechanisms are defined by specific biochemical and subcellular alterations, ranging from stem cell reprogramming in metaplasia to precise proteolytic cascades in apoptosis and structural protein denaturation in coagulative necrosis.

Question 557Question →

A hematology consultation service is evaluating four patients with undiagnosed bleeding diatheses and suspected hereditary coagulopathies. Pair each patient's clinical presentation and initial laboratory screening with the specific confirmatory diagnostic finding that best establishes the underlying defect.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The presentations map to classic laboratory findings for Glanzmann thrombasthenia, Factor XIII deficiency, Dysfibrinogenemia, and Bernard-Soulier syndrome.

Each clinical presentation describes a classic hereditary bleeding or coagulation disorder that requires specialized laboratory testing beyond standard PT/aPTT panels. By correlating the cellular or molecular defect with its distinct in vitro behavior, the correct pathophysiology is matched precisely to the diagnostic assay.

Step-by-Step Solution

Analyze the 24-year-old female with absent response to ADP/epinephrine.

Identified as Glanzmann thrombasthenia, which uniquely shows normal ristocetin agglutination.

Deficiency of GPIIb/IIIa impairs aggregation to standard agonists but preserves ristocetin-induced agglutination via the intact GPIb receptor.

Evaluate the 4-year-old boy with delayed umbilical stump bleeding and normal standard coagulation times.

Identified as Factor XIII deficiency, confirmed by clot dissolution in 5M urea.

Factor XIII stabilizes fibrin but its activity is not captured by PT/aPTT assays; the clot solubility test is the definitive diagnostic step.

Assess the 32-year-old female with prolonged thrombin time, pregnancy loss, and normal PT/aPTT.

Identified as dysfibrinogenemia, characterized by discordant functional/antigenic levels and prolonged reptilase time.

Structurally abnormal fibrinogen prolongs TT and reptilase time while demonstrating a mismatch between quantity (antigenic) and quality (functional).

Analyze the 17-year-old male with macrothrombocytopenia and epistaxis.

Identified as Bernard-Soulier syndrome, defined by absent ristocetin response that does not correct with plasma.

The absence of the GPIb receptor prevents ristocetin-induced agglutination, and because the defect is cellular rather than humoral, donor plasma cannot correct it.

Key Concept

Diagnostic laboratory evaluation of specialized coagulation factor defects and hereditary platelet function disorders

Question 558Question →

A 32-year-old man presents to the physical therapy clinic for his initial evaluation following a right knee anterior cruciate ligament (ACL) reconstruction. For the past four weeks, his right lower extremity has been immobilized in a rigid extension brace, and he has been strictly non-weight-bearing. On physical examination, the surgical incisions are well-healed without erythema or discharge. However, the circumference of his right mid-thigh is 4.5 cm less than that of his left mid-thigh. He reports no pain or paresthesias in the limb. Which of the following intracellular processes is primarily responsible for the macroscopic changes observed in this patient's right lower extremity?

Covalent attachment of ubiquitin to cytoskeletal proteins

Release of cytochrome c from the mitochondrial intermembrane space

Massive influx of extracellular calcium across the plasma membrane

Transformation of mature skeletal muscle cells into adipocytes

Failure of the ATP-dependent sodium-potassium pump

Show answer & explanation

Answer: Covalent attachment of ubiquitin to cytoskeletal proteins

Answer

The correct answer is the covalent attachment of ubiquitin to cytoskeletal proteins, which facilitates targeted protein degradation.

The patient's clinical presentation of muscle wasting after prolonged casting is a classic example of disuse atrophy. At the cellular level, atrophy is characterized by a reduction in the size of the cell to achieve a new equilibrium with a reduced workload or nutrient supply. This shrinkage is achieved through decreased protein synthesis and increased protein degradation. The primary mechanism for degrading intracellular proteins in this context is the ubiquitin-proteasome pathway. Nutrient deficiency or disuse activates ubiquitin ligases, which attach ubiquitin molecules to target cytoskeletal proteins. These 'tagged' proteins are then recognized and degraded by the proteasome.

Step-by-Step Solution

Analyze the clinical presentation and physical exam findings.

The patient has a 4.5 cm reduction in thigh circumference after four weeks of immobilization, indicating profound muscle wasting.

Establishing the clinical diagnosis of disuse atrophy is the first step before determining the subcellular mechanism.

Determine the cellular adaptation taking place.

The skeletal muscle cells have undergone atrophy (shrinkage in cell size), rather than necrosis or apoptosis.

Matching the clinical sign (muscle wasting without inflammation or cell death) to the correct adaptive response narrows down the potential molecular pathways.

Identify the primary molecular mechanism of cellular atrophy.

Atrophy occurs via decreased protein synthesis and increased protein degradation, primarily driven by the ubiquitin-proteasome pathway.

This directly answers the stem's question regarding the intracellular process responsible for the macroscopic changes.

Key Concept

Disuse atrophy of skeletal muscle is a reversible cellular adaptation characterized by decreased cell size, primarily mediated by increased degradation of cytoskeletal proteins via the ubiquitin-proteasome pathway.

Question 559Question →

A 75-year-old man presents to the outpatient clinic reporting a 3-month history of progressive exertional shortness of breath and occasional lightheadedness when climbing stairs. His vital signs are within normal limits. On physical examination, palpation of the carotid arteries reveals a pulse with a decreased amplitude and a delayed upstroke. Cardiac auscultation reveals a harsh, crescendo-decrescendo systolic murmur heard best at the right second intercostal space with radiation to the carotid arteries. Based on these physical examination findings, which of the following is the most likely diagnosis?

Aortic stenosis

Aortic regurgitation

Mitral regurgitation

Mitral stenosis

Tricuspid regurgitation

Show answer & explanation

Answer: Aortic stenosis

Answer

Aortic stenosis

The correct diagnosis is Aortic stenosis. The physical examination findings presented are textbook hallmarks of this valvular disease. The delayed and weakened carotid pulse ('pulsus parvus et tardus') occurs because the narrowed aortic valve restricts left ventricular outflow, resulting in a slow rise in systemic arterial pressure. Furthermore, the harsh, crescendo-decrescendo systolic murmur heard at the right second intercostal space with radiation to the carotid arteries is the characteristic auscultatory finding of blood being forced through a stenotic aortic valve. These findings directly explain the patient's exertional symptoms.

Step-by-Step Solution

Analyze the characteristics of the patient's arterial pulse.

The carotid pulse exhibits a decreased amplitude and a delayed upstroke, classically known as pulsus parvus et tardus.

Identifying the specific pulse contour helps differentiate among left-sided valvular and vascular pathologies.

Evaluate the cardiac auscultation findings.

There is a harsh, crescendo-decrescendo systolic murmur located at the right second intercostal space that radiates to the carotids.

The timing (systolic), shape (crescendo-decrescendo), location, and radiation pattern of a murmur are key to localizing the structural defect.

Synthesize the physical examination findings to establish a diagnosis.

The combination of pulsus parvus et tardus and a classic aortic ejection murmur firmly points to severe narrowing of the aortic valve.

Matching isolated physical signs to form a cohesive clinical syndrome ensures diagnostic accuracy.

Key Concept

Physical examination hallmarks of Aortic Stenosis

Estimated Time:45s

Question 560Question →

A 58-year-old man is brought to the emergency department due to a persistent nosebleed that began 3 hours ago. He has a history of type 2 diabetes mellitus, hypertension, and end-stage renal disease. The patient reports missing his last three hemodialysis sessions due to a lack of transportation. His blood pressure is 168/92 mmHg, and his heart rate is 94/min. Physical examination shows continuous oozing of blood from both nares despite the application of direct pressure and anterior nasal packing. Laboratory studies reveal the following:

Hemoglobin: 9.2 g/dL
Platelet count: 210,000/mm³
Blood urea nitrogen: 96 mg/dL
Serum creatinine: 7.8 mg/dL
Prothrombin time: 11 seconds
Partial thromboplastin time: 26 seconds

Which of the following best describes the mechanism of action of the most appropriate initial pharmacologic therapy for this patient's bleeding?

Stimulation of endothelial cells to release stored von Willebrand factor

Replenishment of circulating coagulation factors to promote fibrin formation

Provision of functional donor platelets to overcome circulating inhibitors

Competitive inhibition of plasminogen activation to stabilize existing clots

Cleavage of ultra-large von Willebrand factor multimers to restore microcirculation

Show answer & explanation

Answer: Stimulation of endothelial cells to release stored von Willebrand factor

Answer

The most appropriate initial pharmacologic therapy is desmopressin (DDAVP), which works by stimulating endothelial cells to release stored von Willebrand factor.

The patient is experiencing acute mucosal bleeding due to uremic platelet dysfunction, a consequence of his missed hemodialysis sessions leading to the accumulation of uremic toxins. These toxins interfere with platelet-platelet and platelet-endothelium interactions, specifically impairing von Willebrand factor (vWF) binding and glycoprotein IIb/IIIa function. This results in defective primary hemostasis characterized by a prolonged bleeding time, but a normal platelet count, prothrombin time (PT), and partial thromboplastin time (PTT). The most appropriate initial pharmacologic therapy is desmopressin (DDAVP). DDAVP is a synthetic analogue of vasopressin that stimulates the release of vWF and factor VIII from the Weibel-Palade bodies of endothelial cells. The sudden increase in circulating high-molecular-weight vWF multimers enhances platelet adhesion to the damaged endothelium, effectively arresting the bleeding. While resuming hemodialysis is the definitive treatment to clear the uremic toxins, DDAVP is utilized for rapid, short-term hemostatic control.

Step-by-Step Solution

Analyze the patient's clinical presentation and laboratory results.

The patient has mucosal bleeding (epistaxis), elevated BUN and creatinine due to missed dialysis, a normal platelet count, and normal coagulation studies (PT, PTT).

To accurately diagnose the underlying cause of the bleeding.

Identify the primary pathophysiologic defect based on the clinical findings.

The findings indicate uremic platelet dysfunction, a qualitative platelet defect caused by the accumulation of uremic toxins (e.g., guanidinosuccinic acid) that impair platelet adhesion and aggregation.

Understanding the precise defect is essential for selecting targeted, effective therapy.

Determine the most appropriate initial pharmacologic intervention and its cellular mechanism.

Desmopressin (DDAVP) is the appropriate initial pharmacotherapy. It acts by inducing the exocytosis of von Willebrand factor and factor VIII from endothelial Weibel-Palade bodies, temporarily correcting the adhesion defect.

While resuming hemodialysis is the definitive treatment to clear the toxins, DDAVP provides rapid, short-term hemostasis in acute bleeding scenarios.

Key Concept

Uremic platelet dysfunction causes abnormal primary hemostasis despite a normal platelet count and normal coagulation studies. Desmopressin (DDAVP) is the initial pharmacotherapy of choice, acting by releasing stored von Willebrand factor from endothelial cells to facilitate platelet adhesion.

PreviousPage 28 / 237Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept